Lataa...
Naproxen in rheumatoid arthritis. Extended trial.
121 patients with active rheumatoid arthritis, 91 of whom had proved intolerant of other nonsteroidal anti-inflammatory agents, were treated for a mean of 10 months with naproxen. A dosage of 250 mg twice daily produced sustained improvement in most of the standard clinical measurements. 28 patients...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
1976
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1006592/ https://ncbi.nlm.nih.gov/pubmed/795386 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|